NLRP3炎症小体对龋病诱发牙髓炎症的调控:一项基于实验室的研究
在龋病诱发牙髓炎的牙髓组织和牙髓细胞中检测NLRP3炎症小体的表达与功能,并用THP-1巨噬细胞和离体牙髓炎模型评估LTA、LPS及MCC950的作用。结果显示LTA显著上调NLRP3和IL-1β表达并促进ASC斑点形成,MCC950显著降低IL-1β和IL-6,但对IL-8和MMP-9无影响;NLRP3抑制剂可能成为值得进一步研究的治疗靶点。
要点
- NLRP3炎症小体在健康牙髓与龋坏牙髓中差异表达。
- LTA处理牙髓细胞显著上调NLRP3和IL-1β表达(p < .05)。
- MCC950显著降低离体牙髓炎模型IL-1β和IL-6(p < .01)。
核心结论
- NLRP3炎症小体在龋病及LTA处理中表达上调,提示其参与龋病诱发牙髓炎。
- NLRP3抑制剂减轻选择性炎症细胞因子的释放,可能是值得进一步研究的潜在治疗靶点。
研究设计与样本
- 实验室研究:用免疫组化检测牙髓组织、qPCR检测牙髓细胞中NLRP3表达。
- 用表达ASC-GFP融合蛋白的THP-1巨噬细胞,经LPS和LTA处理后活细胞成像评估NLRP3炎症小体活化。
- 用Caspase I抑制剂确认炎症小体活化。
- 采用牙髓细胞与THP-1巨噬细胞共培养的离体牙髓炎模型研究MCC950的作用。
- 用ELISA和多因子阵列检测细胞因子,数据采用t检验或方差分析加Bonferroni事后检验,显著性水平设为p ≤ .05。
主要发现
- NLRP3炎症小体在健康牙髓与龋坏牙髓中差异表达。
- LTA处理牙髓细胞显著上调NLRP3和IL-1β表达(p < .05),且较LPS诱导更多ASC斑点形成。
- Caspase I抑制剂显著减少LTA处理后的IL-1β释放(p < .01),提示炎症小体依赖机制。
- MCC950显著降低离体牙髓炎模型中的IL-1β和IL-6(p < .01),但对IL-8和MMP-9无影响。
关键数值与推荐
- LTA处理牙髓细胞上调NLRP3和IL-1β表达,p < .05。
- Caspase I抑制剂减少LTA诱导的IL-1β释放,p < .01。
- MCC950降低离体牙髓炎模型IL-1β和IL-6,p < .01;对IL-8和MMP-9无影响。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIM: To evaluate the expression and function of the nod-like receptor pyrin domain containing 3 (NLRP3) inflammasome in caries induced pulpitis. METHODOLOGY: NLRP3 expression was determined with immunohistochemistry in the dental pulp and qPCR in dental pulp cells (DPCs). THP-1 macrophages expressing the apoptosis-related speck-like protein (ASC) and green fluorescent protein (GFP) fusion protein were used to assess NLRP3 inflammasome activation by live cell imaging, following treatment with lipopolysaccharide (LPS) and lipoteichoic acid (LTA). Caspase I inhibitor was used to confirm inflammasome activation. An ex-vivo pulpitis model in which the DPCs were co-cultured with THP-1 macrophages was used to study the effect of the NLRP3 inflammasome inhibitor (MCC950), and cytokines were measured using ELISA and multiplex array. Data were analysed using the t-test or anova followed by a Bonferroni post hoc test with the level of significance set at p ≤ .05. RESULTS: NLRP3 inflammasome was differentially expressed in dental pulp of sound and carious teeth. Treatment of DPCs with LTA significantly upregulates NLRP3 and IL-1 β-expression (p < .05) and in induces more ASC specks formation compared to LPS. IL-β release in response to LTA treatment is significantly reduced with Caspase I inhibitor suggesting inflammasome dependent mechanism (p < .01). NLRP3-specific inhibitor, MCC950, significantly reduced IL-1β and IL-6 in an ex-vivo pulpitis model (p < .01) but had no effect on IL-8 or matrix metalloproteinase-9 (MMP-9). CONCLUSIONS: Expression and upregulation of NLRP3 inflammasome with caries and LTA treatment suggest a role in caries-induced pulpitis. NLRP3 inhibitor attenuated the release of selective inflammatory cytokines and could be a potential treatment target that merit further investigation.
引用
- Al Natour B, Lundy FT, About I, et al. Regulation of caries-induced pulp inflammation by NLRP3 inflammasome: A laboratory-based investigation. Int Endod J. 2022. PMID: 36287083. doi:10.1111/iej.13855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。